A comparative study of efficacy the Panchtikta Ghrita Matra Vasti and Panchtikta Ghrita Marsha Nasya in Cervical Spondylosis

Datta Meghe Institute of Medical Sciences Deemed to be University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of either sex with presenting classical symptoms of cervical spondylosis
•X-ray suggesting cervical spondylopsis confirmed by qualified radiologist
•Patients above 18 years and <60 years
•Patient who can make neck extension up to 45 degree angle

•Age group below 18 years and above 60 years
•Cervical Spondylosis with myelopathy and radiculopathy ( ICD 10 criteria M47.8)
•Contraindication and previously treated with Vasti therapy
•Nasya anarha
•Pregnant and lactating mothers
•Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy
•Stenosis of the spinal canal
•Patients suffering from any infectious disease (like tuberculosis), metabolic disease (like diabetes mellitus and hypothyroidism), orchronic diseases (such as rheumatoid arthritis, systematic lupus erythromatous, and ankylosing spondylitis)

发起方

Datta Meghe Institute of Medical Sciences Deemed to be University